You are visiting this page from United States of America. We can configure regional settings to adapt price and delivery display. Do you want to apply these parameters?

DulcoSoft Drinkable Solution 250ml

Bottle of 250ml
£6.30
£25.20 per kg/L
In stock
Delivery at home
From October 2nd, 2020
View all the delivery methods for this item
Country of delivery:
Hermes Delivery 4 to 8 days is £5.50
Free from £45
DPD Delivery 3 to 7 days is £5.99
Free from £49
Chronopost Delivery 2 to 3 days is £7.99
Free from £99
DHL Express Delivery 1 to 2 days is £15.99
Free from £299
By buying this product, I benefit from:
£0.13 on my loyalty card
Description

DulcoSoft Drinkable Solution 250ml is a medical device based on Macrogol in of a drinkable solution with flavor free to dissolve.

Dulcosoft is a laxative used for the symptomatic treatment of constipation, and it allows to soften the hard feces and to facilitate disposal. It effectively relieves constipation.

Use

Adult and child from 8 years and more : 20 to 40ml of solution per day, to take preferably in once in the morming.

Indication: To relieve constipation.
Composition

Potassium Sorbate (Preservative), Macrogol 400, Citric Acid, Purified Water.

Details
EAN Code 3401563017318
Form Solution
Presentation Bottle
Contents 250ml
Last reviews on this item
DulcoSoft Drinkable Solution 250ml
DulcoSoft Drinkable Solution 250ml is rated 3.0 out of 5 by 2.

Rated 4 out of 5 by from OK - I was already familiar with the product
Date published: 2019-12-07
Rated 2 out of 5 by from Do not really work
Date published: 2018-03-23

Discover the brand Boehringer Ingelheim

Boehringer Ingelheim is a french pharmaceutical group, subsidiary of one of the 20 largest pharmaceutical world laboratories.

For more than 40 years, the Boehringer Ingelheim pharmaceutical group creates drugs sold on medical prescription (for chronic diseases to medical urge), products for family medication and veterinary products.

The Boehringer Ingelheim group is known for its commitment in research and development, that allows it to keep on developing new drugs in order to improve the health of patients.

Cocooncenter

Continuing your navigation, you accept the use of cookies that will allow us to offer contents and advertising linked to your interests.

Learn more
Newsletter
Subscribe to the newsletter to benefit from our privilege offers
×